Response to ERBB3-Directed Targeted Therapy in NRG1-Rearranged Cancers.
Cancer Discov. 2018 Jun;8(6):686-695. doi: 10.1158/2159-8290.CD-17-1004. Epub 2018 Apr 2.
Cancer Discov. 2018.
PMID: 29610121
Free PMC article.
Clinical Trial.